Search clinical trials for: ACP-196, Active metabolite
Total 8700 results
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaAustria, Italy, Spain, United Kingdom, Belgium, Taiwan, France, Korea, Republic of, Hungary, United States, Ukraine, Canada, Australia, Germany, Israel, Czechia, Russian Federation, Slovakia, Poland, Bulgaria, New Zealand, Sweden, C... and more
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Pancreatic CancerUnited States
-
National Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | NHL | DLBCLUnited States
-
Acerta Pharma BVAstraZenecaActive, not recruitingMultiple Myeloma | Non-Hodgkins Lymphoma | B-AllUnited States
-
Weill Medical College of Cornell UniversityAstraZenecaWithdrawnChronic Lymphocytic Leukemia | CLL/SLLUnited States
-
Acerta Pharma BVCompleted
-
Acerta Pharma BVCompletedA Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196Healthy ParticipantsUnited States
-
Narendranath EpperlaWithdrawnRecurrent Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Nodal Marginal Zone Lymphoma | Recurrent Nodal Marginal Zone Lymphoma | Recurrent Splenic Marginal Zone Lymphoma | Refractory Splenic Marginal Zone Lymphoma and other conditions
-
Acerta Pharma BVCompletedHepatic InsufficiencyUnited States
-
Baker Heart and Diabetes InstituteCompletedDiabetic NephropathiesAustralia
-
Acerta Pharma BVActive, not recruitingWaldenström Macroglobulinemia (WM)Spain, United States, United Kingdom, France, Italy, Greece, Netherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Acerta Pharma BVWithdrawn
-
Acerta Pharma BVActive, not recruitingMantle Cell Lymphoma (MCL)Belgium, France, United Kingdom, United States, Italy, Poland, Netherlands, Australia, Czechia, Spain
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Autoimmune Hemolytic Anemia | Warm Antibody Autoimmune Hemolytic Anemia | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
Acerta Pharma BVTerminatedDLBCL | Richter SyndromeUnited Kingdom, United States
-
Acerta Pharma BVCompletedRheumatoid ArthritisUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Moderate-Severe Chronic Graft Versus Host DiseaseUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR)Completed
-
Acerta Pharma BVAstraZenecaCompletedDiffuse Large B Cell Lymphoma | NHL | Non-hodgkin's Lymphoma | DLBCLUnited States, United Kingdom
-
Jonsson Comprehensive Cancer CenterAstraZenecaRecruitingDiffuse Large B-Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | Secondary Central Nervous System LymphomaUnited States
-
University of SheffieldSheffield Teaching Hospitals NHS Foundation Trust; South Yorkshire and Bassetlaw...UnknownNurse's Role | ACP | Development, ConsensusUnited Kingdom
-
Acerta Pharma BVMerck Sharp & Dohme LLCActive, not recruitingMultiple Myeloma | Hodgkin Lymphoma | Waldenström Macroglobulinemia | Burkitt Lymphoma | Small Lymphocytic Lymphoma (SLL) | Hairy Cell Leukemia | CLL | Mantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Richter's Syndrome | Indolent Non Hodgkin Lymphoma | Marginal Zone Lymphomas | Mediastinal Large B Cell...United States
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedOvarian CancerUnited States
-
Acerta Pharma BVAcerta Pharma, LLCCompletedMultiple Myeloma (MM)United States, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
Fuji Yakuhin Co., Ltd.Completed
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Acerta Pharma BVCompleted
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Emory UniversityNational Cancer Institute (NCI); AstraZenecaRecruitingMantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Lymphoproliferative Disorder | Indolent Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Urothelial CarcinomaUnited States
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
University of WashingtonAstraZenecaRecruitingB-Cell Non-Hodgkin Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Follicular Lymphoma to Diffuse...United States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, United Kingdom, Belgium, Spain, Israel, France
-
Acerta Pharma BVCompletedHealthy ParticipantsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's SyndromeUnited States, United Kingdom, Italy
-
AstraZenecaParexelActive, not recruitingChronic Lymphocytic LeukemiaUnited States, France, Italy, Spain, Sweden, Canada, Denmark, Korea, Republic of, Brazil, Russian Federation, Taiwan, Germany, Australia, Netherlands, Finland, Norway, United Kingdom
-
Acerta Pharma BVActive, not recruitingActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)United States, United Kingdom
-
Acerta Pharma BVAstraZenecaActive, not recruitingNon Hodgkin LymphomaUnited States, Canada, Italy
-
German CLL Study GroupActive, not recruitingChronic Lymphoid LeukemiaAustria, Germany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States